Joachim Yahalom
REFERENCE: Education Session: Saturday June 3rd, 2006 ASCO Annual Meeting, June 2-6, Atlanta
Joachim Yahalom, Memorial Sloan-Kettering Cancer Center, New York
Should patients with low-risk early stage
 Michael Wilson |  Sarah Berga |  Paul Devroey |
 Arlene Forastiere |  Everett Vokes |  Michael Skinner |  Mark Chambers |
Andy Haines, London School of Hygiene and Tropical Medicine
 Robert Ozols |  Lawrence Wickerham |  Patricia Ganz |  Jorma Paavonen |  Noah Kauff |
Robert Ozols of the Fox Chase Cancer Center in Philadelphia joins Derek Thorne to talk about the top presentations on cancer prevention.
– Raloxifene is as good as tamoxifen at
 Robert Mayer |  Thierry Facon |  Ibrahim Yakoub-Agha |  Peter Paschka |
Robert Mayer of the Dana-Farber Cancer Institute in Boston joins Derek Thorne to discuss the major hematologic malignancy news reported at the 2006 ASCO meeting.
– Older patients with multiple myeloma can
 Dean Bajorin |  Robert Motzer |  Gary Hudes |  Marshall Posner |
Some major progress in kidney cancer and head and neck cancer was announced at the ASCO meeting in Atlanta, and the Audio Journal of Oncology has all the details, plus expert comment
 Julie Gralow |  Charles Geyer |  Judith Bliss |  Robert Coleman |
Julie Gralow, from the Fred Hutchinson Cancer Research Center in Seattle, joins Derek Thorne to talk about the latest news from the ASCO annual meeting in Atlanta.
– In women with
 George Canellos |  Carmela Pepe |  John Goldman |
 Roy Herbst |  Sandra Horning | |
– Elderly patients